SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Valind A) "

Sökning: WFRF:(Valind A)

  • Resultat 1-21 av 21
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  • Langstrom, B, et al. (författare)
  • PET i klinisk verksamhet.
  • 1995
  • Ingår i: Läkartidningen. ; 92, s. 3202-
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
5.
  •  
6.
  • ANDERSSON, JLR, et al. (författare)
  • A METHOD FOR COREGISTRATION OF PET AND MR BRAIN IMAGES
  • 1995
  • Ingår i: JOURNAL OF NUCLEAR MEDICINE. - : SOC NUCLEAR MEDICINE INC. - 0161-5505. ; 36:7, s. 1307-1315
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Combining MRI morphological data with functional PET data offers significant advantages in research as well as in many clinical situations. Automatic methods are needed, however, to coregister the data from the two modalities. Methods: Simulated PET imag
  •  
7.
  • Andersson, JLR, et al. (författare)
  • Regional cerebral blood flow and oxygen metabolism during migraine with and without aura
  • 1997
  • Ingår i: CEPHALALGIA. - : SCANDINAVIAN UNIVERSITY PRESS. - 0333-1024. ; 17:5, s. 570-579
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Eleven cases of migraine with and without aura were investigated with positron emission tomography (PET). Regional cerebral blood flow (rCBF), oxygen metabolism (rCMRO(2)) and oxygen extraction (rOER) were measured during baseline (n = 11), aura (n = 6),
  •  
8.
  •  
9.
  •  
10.
  •  
11.
  • Aziz, Q, et al. (författare)
  • Identification of human brain loci processing esophageal sensation using positron emission tomography
  • 1997
  • Ingår i: Gastroenterology. - 0016-5085 .- 1528-0012. ; 113:1, s. 50-59
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND & AIMS:Brain loci that process human esophageal sensation remain unidentified. The aim of this study was to identify the brain loci that process nonpainful and painful human esophageal sensation.METHODS:In 8 healthy subjects (7 men; age range, 24-47 years), distal esophageal stimulation was performed by repeatedly inflating a balloon at volumes that produced either no sensation, definite sensation, or pain. Two positron emission tomography scans were performed for each sensation using H2(15)O. Magnetic resonance brain scans were also performed in each subject, and the positron emission tomography data were coregistered with magnetic resonance scans. Analysis of covariance-corrected t images showing the contrasts definite sensation-baseline, pain-baseline, and pain-definite sensation were created.RESULTS:Nonpainful stimulation elicited bilateral activations along the central sulcus, insular cortex, and frontal/parietal operculum (P < 0.01). Painful stimulation produced more intense activations of the same areas and additional activation of the right anterior insular cortex and the anterior cingulate gyrus. Multiple areas of decreased activation were also observed; prominent among these was the right prefrontal cortex, which was inhibited during both nonpainful and painful stimulation.CONCLUSIONS:Esophageal sensation activates bilaterally the insula, primary somatosensory cortex, and operculum. The right anterior insular cortex and anterior cingulate gyrus process esophageal pain.
  •  
12.
  •  
13.
  •  
14.
  •  
15.
  • Granqvist, P, et al. (författare)
  • Sensed presence and mystical experiences are predicted by suggestibility, not by the application of transcranial weak complex magnetic fields
  • 2005
  • Ingår i: Neuroscience Letters. - : Elsevier BV. - 0304-3940. ; 379:1, s. 1-6
  • Tidskriftsartikel (refereegranskat)abstract
    • Transcranial magnetic stimulation (TMS) with weak (micro Tesla) complex waveform fields have been claimed to evoke the sensed presence of a sentient being in up to 80% in the general population. These findings have had a questionable neurophysiological foundation as the fields are approximately six orders of magnitude weaker than ordinary TMS fields. Also, no independent replication has been reported. To replicate and extend previous findings, we performed a double-blind experiment (N = 89), with a sham-field control group. Personality characteristics indicating suggestibility (absorption, signs of abnormal temporal lobe activity, and a "new age"-life-style orientation) were used as predictors. Sensed presence, mystical, and other somatosensory experiences previously reported from the magnetic field stimulation were outcome measures. We found no evidence for any effects of the magnetic fields, neither in the entire group, nor in individuals high in suggestibility. Because the personality characteristics significantly predicted outcomes, suggestibility may account for previously reported effects. Our results strongly question the earlier claims of experiential effects of weak magnetic fields.
  •  
16.
  • Mattsson, S., et al. (författare)
  • Radiation Dose to Patients from from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances.
  • 2015
  • Rapport (övrigt vetenskapligt/konstnärligt)abstract
    • This report provides a compendium of current information relating to radiation dose to patients, including biokinetic models, biokinetic data, dose coefficients for organ and tissue absorbed doses, and effective dose for major radiopharmaceuticals based on the radiation protection guidance given in Publication 60 (ICRP, 1991). These data were mainly compiled from Publications 53 , 80, and 106 (ICRP, 1987, 1998, 2008), and related amendments and corrections. This report also includes new information for 82 Rb-chloride, iodide (123 I, 124 I, 125 I, and 131 I) and 123 Ilabelled 2.-carbomethoxy 3.-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (FPCIT). The coefficients tabulated in this publication will be superseded in due course by values calculated using new International Commission on Radiation Units and Measurements/International Commission on Radiological Protection adult and paediatric reference phantoms and Publication 103 methodology (ICRP, 2007). The data presented in this report are intended for diagnostic nuclear medicine and not for therapeutic applications.
  •  
17.
  •  
18.
  •  
19.
  • Valind, Anders, et al. (författare)
  • ZMIZ1-associated neurodevelopmental disorder and Hirschsprung disease
  • 2021
  • Ingår i: Journal of Pediatric Surgery Case Reports. - : Elsevier BV. - 2213-5766. ; 71
  • Tidskriftsartikel (refereegranskat)abstract
    • De novo mutations in the gene encoding transcription factor ZMIZ1, located on chromosome 10q22, were recently found to be associated with a novel neurodevelopmental syndrome [1]. In this case report we present a patient with developmental delay and Hirschsprung disease, who carries a de novo mutation in ZMIZ1. Utilizing public gene expression data from mouse we confirm that ZMIZ1 is indeed expressed in progenitors of the enteric nervous system (ENS) as well as in a subpopulation of ENS neurons in the adult mouse and based on this we then propose that ZMIZ1 is a novel putative risk gene for HD.
  •  
20.
  •  
21.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-21 av 21

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy